Brief: Vistagen Announces Stockholder-Approved Reverse Stock Split
June 6 (Reuters) - VistaGen Therapeutics Inc VTGN.O :
* VISTAGEN ANNOUNCES STOCKHOLDER-APPROVED REVERSE STOCK
SPLIT
* COMMON STOCK WILL BEGIN TRADING ON A SPLIT-ADJUSTED BASIS
AT
OPENING OF TRADING ON NASDAQ CAPITAL MARKET ON JUNE 7
* APPROVED REVERSE STOCK SPLIT OF ITS OUTSTANDING SHARES OF
COMMON
STOCK, AT A RATIO OF ONE-FOR-THIRTY
Source text for Eikon: ID:nBw2GHX4Da
Further company coverage: VTGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vistagen Therapeutics
See all newsBrief: Vistagen TherapeuticsSays Fasedienol Nasal Spray Well-Tolerated With No New Drug-Related Safety Findings After 12 Months
VistaGen Q1 revenue rises on licensing agreement expiration
Brief: VistaGen Q1 EPS USD -0.3
Vistagen Therapeutics Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Vistagen Appoints Douglas J. Williamson To Its Board Of Directors